Prospective Validation of a DNA Damage Repair-Hippo Pathway Signature in Patients With Advanced Gastric Cancer

NCT06204523 · clinicaltrials.gov ↗

UNKNOWN

Status

167

Enrollment

OTHER

Sponsor class

Conditions

DNA Damage
Gastric Cancer

Interventions

DIAGNOSTIC_TEST: investigated biomarkers regarding the efficacy of first-line chemotherapy

Sponsor

Regina Elena Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]